Results 151 to 160 of about 202,333 (300)

A call for ethical, equitable, and effective artificial intelligence to improve care for all people with epilepsy: A roadmap. A report by the ILAE Global Advocacy Council and Big Data Commission

open access: yesEpilepsia, EarlyView.
Abstract The artificial intelligence (AI) revolution is upon us. It will inevitably form a central component of epilepsy workflows and patient advocacy. Therefore, it behooves us as health care providers to ride the crest of this wave and guide its direction for the benefit of all people with epilepsy.
Colin B. Josephson   +13 more
wiley   +1 more source

Functionality of symptoms and interpersonal communication in home video recordings of functional/dissociative versus epileptic seizures

open access: yesEpilepsia, EarlyView.
Abstract Objective Conceptualizing functional/dissociative seizures (FDS) as resulting from dissociation, or conversion, we hypothesized that, compared to epileptic seizures (ES), FDS should carry more symbolic or communicative content and that this would allow observers to distinguish FDS from ES.
Nayrin Dissouky   +8 more
wiley   +1 more source

Genetic epilepsies with myoclonic seizures: Mechanisms and syndromes

open access: yesEpilepsia Open, EarlyView.
Abstract Genetic epilepsy with myoclonic seizures encompasses a heterogeneous spectrum of conditions, ranging from benign and self‐limiting forms to severe, progressive disorders. While their causes are diverse, a significant proportion stems from genetic abnormalities.
Antonietta Coppola   +3 more
wiley   +1 more source

Neuroimaging of the Syllable Repetition Task in Children With Residual Speech Sound Disorder. [PDF]

open access: yesJ Speech Lang Hear Res, 2021
Spencer C   +6 more
europepmc   +1 more source

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

open access: yesEpilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang   +3 more
wiley   +1 more source

The Prevalence of Speech and Language Disorders in Patients Referred to Speech Therapy Clinics of Hamadan University of Medical Sciences from 2013 to 2022 [PDF]

open access: yesپزشکی بالینی ابن سینا
Background and Objective: Knowledge of the prevalence of speech and language disorders (SLDs) can help speech and language pathologists (SLPs) in planning effective rehabilitation interventions.
Bahareh Rezaei, Ailin Talimkhani
doaj  

Home - About - Disclaimer - Privacy